[go: up one dir, main page]

RS56491B1 - Kompozicije i postupci za supresiju proliferacije endometrijuma - Google Patents

Kompozicije i postupci za supresiju proliferacije endometrijuma

Info

Publication number
RS56491B1
RS56491B1 RS20171065A RSP20171065A RS56491B1 RS 56491 B1 RS56491 B1 RS 56491B1 RS 20171065 A RS20171065 A RS 20171065A RS P20171065 A RSP20171065 A RS P20171065A RS 56491 B1 RS56491 B1 RS 56491B1
Authority
RS
Serbia
Prior art keywords
progesterone
period
cdb
administration
treatment
Prior art date
Application number
RS20171065A
Other languages
English (en)
Serbian (sr)
Inventor
Joseph S Podolski
Original Assignee
Repros Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc
Priority claimed from PCT/US2007/082432 external-priority patent/WO2008067086A2/en
Publication of RS56491B1 publication Critical patent/RS56491B1/sr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20171065A 2006-10-24 2007-10-24 Kompozicije i postupci za supresiju proliferacije endometrijuma RS56491B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86263206P 2006-10-24 2006-10-24
US88534807P 2007-01-17 2007-01-17
PCT/US2007/082432 WO2008067086A2 (en) 2006-10-24 2007-10-24 Compositions and methods for suppressing endometrial proliferation
EP07871232.0A EP2078032B1 (en) 2006-10-24 2007-10-24 Compositions and methods for suppressing endometrial proliferation

Publications (1)

Publication Number Publication Date
RS56491B1 true RS56491B1 (sr) 2018-01-31

Family

ID=41095733

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171065A RS56491B1 (sr) 2006-10-24 2007-10-24 Kompozicije i postupci za supresiju proliferacije endometrijuma

Country Status (4)

Country Link
CN (2) CN104997789A (uk)
RS (1) RS56491B1 (uk)
TW (1) TWI455716B (uk)
UA (1) UA98124C2 (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105963687A (zh) * 2016-04-27 2016-09-28 张金凤 一种用于治疗慢性盆腔疼痛的复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
ATE194358T1 (de) * 1996-05-01 2000-07-15 Us Gov Health & Human Serv 21-substituierte progesteron derivate als antigestagene
MX2007000273A (es) * 2004-07-09 2007-05-21 Population Council Inc Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.

Also Published As

Publication number Publication date
CN104997789A (zh) 2015-10-28
UA98124C2 (uk) 2012-04-25
TWI455716B (zh) 2014-10-11
CN101528764A (zh) 2009-09-09
TW200822931A (en) 2008-06-01

Similar Documents

Publication Publication Date Title
DK2293797T3 (en) PROGESTERON ANTAGONISTS SUCH AS CDB-4124 TO REDUCE PAIN CONNECTED WITH ENDOMETRIOSIS AND UTERUS FIBROMES
EP2078032B1 (en) Compositions and methods for suppressing endometrial proliferation
RS56491B1 (sr) Kompozicije i postupci za supresiju proliferacije endometrijuma
US20090118253A1 (en) Compositions and methods for treating dysfunctional uterine bleeding
HK1135111A (en) Compositions and methods for suppressing endometrial proliferation
HK1225606A1 (en) Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer
HK1225606A (en) Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer
HK1155085A (en) Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc